US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

NGM NGM Biopharmaceuticals Inc

1.54

0.00 (0.00%)

13 Jun 2024 - Cerrado

Retrasado por 15 minutos

Form 3 - Initial statement of beneficial ownership of securities

NGM Biopharmaceuticals (NASDAQ:NGM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas NGM Biopharmaceuticals.

NGM Biopharmaceuticals (NASDAQ:NGM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas NGM Biopharmaceuticals.

Noticias sobre NGM Biopharmaceuticals Inc NGM

NGM Bio Announces Closing of Tender Offer
Viernes 5 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
Martes 19 de Marzo 2024 (3 meses hace) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Lunes 11 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Lunes 11 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
Lunes 11 de Marzo 2024 (3 meses hace) • GlobeNewswire Inc.

Form SC 13E3 - Going private transaction by certain issuers
Viernes 8 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Form SC 14D9 - Solicitation, recommendation statements
Viernes 8 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Form SC14D9C - Written communication relating to third party tender offer
Lunes 26 de Febrero 2024 (4 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Lunes 26 de Febrero 2024 (4 meses hace) • Edgar (US Regulatory)

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
Lunes 26 de Febrero 2024 (4 meses hace) • GlobeNewswire Inc.

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference
Martes 20 de Febrero 2024 (4 meses hace) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Miércoles 14 de Febrero 2024 (4 meses hace) • Edgar (US Regulatory)

Más de NGM Biopharmaceuticals Inc Artículos de Noticias

Gold vs US Dollar

Verizon Communications

American Express

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones